Synthesis of new substituted pyridine derivatives as potent anti-liver cancer agents through apoptosis induction: In vitro, in vivo, and in silico integrated approaches

• Published in: Bioorganic chemistry 2021-06, Vol.111, p.104877-104877, Article 104877
• Main Authors: Boraei, Ahmed T.A., Eltamany, Elsayed H., Ali, Ibrahim A.I., Gebriel, Sara M., Nafie, Mohamed S.
• Format: Article
• Language: English
• Subjects: Apoptosis; In vivo; Liver cancer; Pyridines; RT-PCR
• ISSN: 0045-2068; 1090-2120
• DOI: 10.1016/j.bioorg.2021.104877

[Display omitted] •Novel substituted pyridine-based derivatives were synthesized and fully characterized.•2-(3-Cyano-4,6-diphenylpyridin-2-yloxy)acetohydrazide 7 was found to be more cytotoxic by showing the lowest IC50 value of 7.26 compared to 5-FU (IC50 = 6.98 µM).•Hit compound 7 significantly stimulated apoptotic liver cancer cell death with 49.78-fold (22.90% compared to 0.46% for the control) arresting cell cycle at Pre-G1 phase by 35.16% of cell population, compared to 1.57% for the control.•Compound 7 exhibited inhibition activity towards PIM-1 kinase in the in silico studies with good ADME pharmacokinetics and also validated as anti-cancer agent through in vivo SEC-model. Liver cancer is the most common type of cancer in many countries. New studies and statistics show rising liver cancer worldwide, so it is essential to seek new agents for this type of cancer. PIM1 has an attractive target in the discovery of cancer medications as it is very much expressed in a variety of malignancies and influences such as tumorigenesis, cell cycle progression, cellular proliferation, apoptosis, and cell migration. Accordingly, a series of pyridones and pyridine-amides were synthesized and tested for anti-liver cancer activity. In the synthetic strategy 4,6-diaryl-3-cyano-2-pyridones 3a-n were synthesized using one-pot four component synthetic method. Structural modifications were done on 4,6-diphenyl-3-cayno-2-pyridone 3a to enhance the activity. Alkylation in the presence of K2CO3 afforded the O-alkylated products 4–6. The acetoxy hydrazide 7 was synthesized and cyclized into 1,3,4-oxadiazolethione 8 which alkylated on sulfur to give 10. Azide-coupling method was used to couple the 2-(pyridin-2-yloxy)acetohydrazide 7 to different amines and amino acid esters to furnish the products 12a-e and 13a-b. The synthesized derivatives were subjected to cytotoxic screening against HepG2 and THLE-2 cells, Compounds 10, 12e and 13a have a remarkable cytotoxic activity with IC50 values (10.7–13.9 µM). Compound 7 was found to be more cytotoxic by showing the lowest IC50 value of 7.26 compared to 5-FU (IC50 = 6.98 µM). It inhibited cell growth by 76.76%. Additionally, it significantly stimulated apoptotic liver cancer cell death with 49.78-fold (22.90% compared to 0.46% for the control) arresting cell cycle Pre-G1 with 35.16% of a cell population, compared to 1.57% for the control. Moreover, it validated the intrinsic apoptosis through upregulation of P53, and other related g